NY-CIRIUM
23.8.2022 14:02:54 CEST | Business Wire | Press release
Cirium, the aviation analytics firm, has announced that former Spirit Airlines CEO, Ben Baldanza and former Indigo CCO, Willy Boulter have joined the Cirium On-Time Performance (OTP) Advisory Board.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220823005442/en/
Cirium is the first and only company that has an OTP Advisory Board in the aviation industry. The Board comprises a collaborative team of external advisors who support Cirium’s OTP Program and reports global Annual and Monthly airline and airport on-time analyses.
“We are delighted to welcome Ben and Willy to the Cirium OTP Advisory Board. Together they bring nearly 80 years of aviation experience to the Board, which will be invaluable for Cirium’s airline and airport OTP Program. They will provide key focus and direction on the big-picture initiatives,” said Jeremy Bowen , CEO at Cirium.
Ben Baldanza is a transformational leader in the US airline industry. He was president and CEO for Spirit Airlines and changed that airline into an ultra-low-cost-airline carrier. Prior to Spirit he held executive roles with US Airways, Continental Airlines and TACA Airlines.
In addition to the Cirium OTP Board, Baldanza currently serves on the Board of Directors for JetBlue Airways, Six Flags Entertainment and several private companies. He also co-hosts a weekly podcast that is now in the top 1% of all podcasts by weekly listeners. Baldanza has also been twice named as one of the industry’s 25 Most Influential Leaders .
Baldanza said: “Airline and airport operational performance is increasingly important as the industry recovers from the pandemic and contends with rising challenges such as forecasting travel demand. Cirium’s OTP Program measures the carriers’ and airports’ operational efficiencies and is the standard for on-time arrival and departure benchmarking.”
Willy Boulter has 40 years’ experience in the airline industry, most recently as CCO at India’s largest airline IndiGo. Prior to IndiGo, Boulter was CCO in the Emirates-sponsored team that turned around TAAG Angola Airlines. He held executive roles at Gulf Air, Etihad Airways, low-cost carrier Sky Express, Virgin Atlantic and Cathay Pacific. Boulter also served in the British Army in the UK, Canada and Hong Kong and is a fellow of the Royal Aeronautical Society.
Boulter said: “It’s a privilege to join the Cirium OTP Advisory Board to help steer an accurate analysis of airline and airport operations. The program has multiple benefits for the industry, not least enabling improved operational performance and tracking aircraft utilization aligned to sustainability targets.”
Baldanza and Boulter join Luis Felipe de Oliveira , Director General at ACI World and Henry H. Harteveldt, President – Travel Industry Analyst at Atmosphere Research Group on the Board.
Click here to download the latest Cirium On-Time Performance Monthly Report.
Ends
About Cirium
Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.
For further information please follow Cirium updates on LinkedIn or Twitter or visit www.cirium.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005442/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno
The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press release
New One-Day Intensive Experience Offered 9 June Ahead of Conference 10-11 June at Tobacco Dock Featuring 10 Stages and 14 Tracks The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
